Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2053035

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2053035

HIV Diagnostics Test Market, By Product, By Test Type, By End User, By Geography

PUBLISHED:
PAGES: 151 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

HIV Diagnostics Test Market is estimated to be valued at USD 5.33 Bn in 2026 and is expected to reach USD 10.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 5.33 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.60% 2033 Value Projection: USD 10.12 Bn

The HIV diagnostics test market has seen significant growth over the past few decades and is expected to grow substantially going forward. This is mainly due to the rise in number of people impacted by HIV/AIDS globally. Early detection of HIV infection plays a vital role in controlling the spread of the disease as well as improves the quality of life of infected individuals with timely treatment initiation. Advancements in diagnostic technologies have enabled development of rapid, simple, and point-of-care HIV testing kits which have improved accessibility and uptake of HIV testing services across all settings.

Market Dynamics

The global HIV diagnostics test market growth is driven by the rising prevalence of HIV/AIDS infections worldwide. According to WHO, around 38 million people were living with HIV in 2021. Favorable government initiatives and regulations regarding HIV/AIDS diagnosis & management also boost the market growth. However, lack of awareness about HIV/AIDS in developing nations and social stigma associated with the disease hamper widespread adoption of diagnostic tests. On the other hand, ongoing R&D towards development of novel diagnostic platforms with enhanced sensitivity and shorter turn-around-time presents multiple growth opportunities in the market.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global HIV diagnostics test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Abbott, Bio-Rad Laboratories Inc., Hologic Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., OraSure Technologies Inc., Becton Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems Inc., Zyomyx Incorporation, Bristol -Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global HIV diagnostics test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HIV diagnostics test market.

Market Segmentation

  • Product
  • Assay Kit
  • Consumables
  • Test Type (Revenue, USD Bn, 2021 - 2033)
  • Antibody Test
  • Antigen/antibody tests
  • Nucleic Acid Test
  • End User
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Homecare Settings
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Company Profiles
  • Abbott
  • Bio-Rad Laboratories Inc.
  • Hologic Inc.
  • Siemens Healthineers
  • F. Hoffmann-La Roche Ltd.
  • Beckman Coulter Inc.
  • OraSure Technologies Inc.
  • Becton Dickinson and Company
  • Merck KGaA
  • Chembio Diagnostic Systems Inc.
  • Zyomyx Incorporation
  • Bristol -Myers Squibb
  • Janssen Pharmaceutica NV
  • QIAGEN N.V.
  • ViiV Healthcare Ltd.
Product Code: CMI422

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Test Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • PEST Analysis

4. HIV Diagnostics Test Market, By Product, 2021 - 2033, (USD BN)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Assay Kit
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
  • Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)

5. HIV Diagnostics Test Market, By Test Type, 2021 - 2033, (USD BN)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Antibody Test
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
  • Antigen/antibody tests
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
  • Nucleic Acid Test
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)

6. HIV Diagnostics Test Market, By End User, 2021 - 2033, (USD BN)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals & Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
  • Diagnostic Laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
  • Homecare Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD BN)

7. HIV Diagnostics Test Market, By Region, 2021 - 2033, (USD BN)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021 - 2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD BN)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (USD BN)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD BN)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hologic Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Beckman Coulter Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OraSure Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Becton Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biosynex SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zyomyx Incorporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bristol -Myers Squibb
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Janssen Pharmaceutica NV
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • QIAGEN N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ViiV Healthcare Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!